MARKET

REVBW

REVBW

Rvltn Bioscnc
NASDAQ
0.0095
-0.0002
-2.06%
Closed 15:55 02/06 EST
OPEN
0.0085
PREV CLOSE
0.0097
HIGH
0.0096
LOW
0.0085
VOLUME
5.50K
TURNOVER
--
52 WEEK HIGH
0.0218
52 WEEK LOW
0.0055
MARKET CAP
--
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at REVBW last week (0126-0130)?
Weekly Report · 4d ago
REVELATION BIOSCIENCES - FILES PROSPECTUS TO RESALE 4.72 MLN SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING
Reuters · 01/30 21:18
Revelation Biosciences Raises $7.3 Million Through Unregistered Warrant Exercise
Reuters · 01/29 11:02
Revelation Biosciences Announces 1-for-4 Reverse Stock Split
Reuters · 01/26 14:55
Weekly Report: what happened at REVBW last week (0119-0123)?
Weekly Report · 01/26 10:03
Revelation Biosciences Raises $11 Million Through Immediate Warrant Exercise
Reuters · 01/26 07:33
Weekly Report: what happened at REVBW last week (0112-0116)?
Weekly Report · 01/19 10:08
Revelation Biosciences Unveils Positive Clinical Data for Gemini in Kidney Disease Treatment
Reuters · 01/14 14:00
More
About REVBW
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVBW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVBW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVBW stock methods without spending real money on the virtual paper trading platform.